🔎 Trials Near Me

Gara Jalqabaatti › Sarcoma Tishuu Laffaa › Massachusetts › Boston

Qorannoo klinikaalii Sarcoma Tishuu Laffaa Boston, MA keessatti

Qorannoo 18 Sarcoma Tishuu Laffaa f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Distance-Based Exercise to Preserve Function and Prevent Disability

Namoota walitti qabaa jira
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute., Boston
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04094610

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06641908

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05732831

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06644755

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05711615

Serial MRI Scans During Radiation Therapy

Namoota walitti qabaa jira
  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04188535

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

Namoota walitti qabaa jira
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 15 hanga 39 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07662239

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06975293

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Brigham and Women's Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT07377747

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT07675967

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital,, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116

Video Education With Result Dependent dIsclosure

Namoota walitti qabaa jira
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05225428

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Namoota walitti qabaa jiraSadarkaa 1/2
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Umuriin 12 hanga 49 · Saalaa hunda · Haaromfame 19-Gur-2026 · NCT06709495

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Onk-2025 · NCT04370587

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Gur-2019 · NCT03838718

Qorannoo Sarcoma Tishuu Laffaa magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.